Please use this identifier to cite or link to this item:
Full metadata record
DC FieldValueLanguage
dc.contributor.authorGan, Peck Yenen_US
dc.contributor.authorLow, Calvin Sin Chyeen_US
dc.contributor.authorChim, Wai Kayen_US
dc.description.abstractThis empirical study attempts to establish the relationship between a firm's voluntary disclosures on research and development and its size, growth options, leverage and its independent auditor's reputation. Based on the results of this study, it was established that for biotechnology firms listed on Nasdaq, there exists a positive relationship between voluntary disclosures on R&D and growth options and/or with firm size. It was also shown that leverage was an insignificant factor in influencing firms' voluntary disclosures on research and development. Due to a lack in variance in data collected, the relationship between voluntary disclosures on research and development and independent auditor's reputation could not be established.en_US
dc.format.extent95 p.
dc.rightsNanyang Technological Universityen_US
dc.titleAn empirical study of voluntary research and development disclosures of biotechnology firms listed on NASDAQen_US
dc.contributor.supervisorTan, Pearl Hock Neoen_US
dc.contributor.schoolCollege of Business (Nanyang Business School)en_US
dc.description.degreeMaster of Business Administration (Accountancy)en_US
item.fulltextWith Fulltext-
Appears in Collections:NBS Theses
Files in This Item:
File Description SizeFormat 
  Restricted Access
10.73 MBAdobe PDFView/Open

Page view(s) 10

Updated on Jan 23, 2021


Updated on Jan 23, 2021

Google ScholarTM


Items in DR-NTU are protected by copyright, with all rights reserved, unless otherwise indicated.